10 immunotherapy companies making waves in 2023
Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is…
March 15, 2023 - 10 minutes
Immunotherapy
How the microbiome can predict cancer immunotherapy success
A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable…
March 14, 2023 - 2 minutes
AELIX announces ‘important step towards HIV eradication’
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies…
February 24, 2023 - 4 minutes
Cytovation melanoma study under way
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its…
February 16, 2023 - 2 minutes
TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million…
February 9, 2023 - 2 minutes
Mnemo Therapeutics and Institut Curie studies lead to cancer-specific targets
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies…
February 7, 2023 - 3 minutes
Next-generation small molecules hold promise for immunotherapy
By Ian B. Walters, chief executive officer and chairman, Portage Biotech In recent years, PD-1/PD-L1…
February 1, 2023 - 3 minutes
The next breakthrough in cancer treatment?
In our body, we have an innate immune system and an immune system that is…
January 31, 2023 - 4 minutes
HKUMed uncovers T cell exhaustion factor driving cancer immunotherapy resistance
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
January 27, 2023 - 2 minutes
Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project…
January 20, 2023 - 4 minutes
Ebvallo approval ushers in off-the-shelf T-cell immunotherapies
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
December 20, 2022 - 6 minutes
Watch: Valo Therapeutics at Bio-Europe
Valo Therapeutics Oy is a Finnish immunotherapy company developing antigen-coated oncolytic viruses and vaccine vectors…
December 20, 2022 - 1 minute
